148 related articles for article (PubMed ID: 28601573)
1. Upregulation of cyclin B1 plays potential roles in the invasiveness of pituitary adenomas.
Zhao P; Zhang P; Hu W; Wang H; Yu G; Wang Z; Li C; Bai J; Zhang Y
J Clin Neurosci; 2017 Sep; 43():267-273. PubMed ID: 28601573
[TBL] [Abstract][Full Text] [Related]
2. CCNB1 affects cavernous sinus invasion in pituitary adenomas through the epithelial-mesenchymal transition.
Li B; Cheng J; Wang H; Zhao S; Zhu H; Li C; Zhang Y; Zhao P
J Transl Med; 2019 Oct; 17(1):336. PubMed ID: 31585531
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of miR-410 targeting the cyclin B1 gene plays a role in pituitary gonadotroph tumors.
Müssnich P; Raverot G; Jaffrain-Rea ML; Fraggetta F; Wierinckx A; Trouillas J; Fusco A; D'Angelo D
Cell Cycle; 2015; 14(16):2590-7. PubMed ID: 26125663
[TBL] [Abstract][Full Text] [Related]
4. MSH6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes.
Uraki S; Ariyasu H; Doi A; Takeshima K; Morita S; Inaba H; Furuta H; Fukuhara N; Inoshita N; Nishioka H; Nakao N; Yamada S; Akamizu T
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325698
[TBL] [Abstract][Full Text] [Related]
5. EZH2 upregulation correlates with tumor invasiveness, proliferation, and angiogenesis in human pituitary adenomas.
Liu B; Pang B; Wang Q; Yang S; Gao T; Ding Q; Liu H; Yang Y; Fan H; Zhang R; Xin T; Xu G; Pang Q
Hum Pathol; 2017 Aug; 66():101-107. PubMed ID: 28666925
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of EpCAM and Trop2 in pituitary adenomas.
Chen X; Pang B; Liang Y; Xu SC; Xin T; Fan HT; Yu YB; Pang Q
Int J Clin Exp Pathol; 2014; 7(11):7907-14. PubMed ID: 25550831
[TBL] [Abstract][Full Text] [Related]
7. Expression of MMP14 in invasive pituitary adenomas: relationship to invasion and angiogenesis.
Hui P; Xu X; Xu L; Hui G; Wu S; Lan Q
Int J Clin Exp Pathol; 2015; 8(4):3556-67. PubMed ID: 26097538
[TBL] [Abstract][Full Text] [Related]
8. N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.
Vaitkiene P; Valiulyte I; Glebauskiene B; Liutkeviciene R
Diagn Pathol; 2017 Apr; 12(1):33. PubMed ID: 28390436
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness.
Qian ZR; Sano T; Asa SL; Yamada S; Horiguchi H; Tashiro T; Li CC; Hirokawa M; Kovacs K; Ezzat S
J Clin Endocrinol Metab; 2004 Apr; 89(4):1904-11. PubMed ID: 15070963
[TBL] [Abstract][Full Text] [Related]
10. Potential biomarkers and lncRNA-mRNA regulatory networks in invasive growth hormone-secreting pituitary adenomas.
Yin H; Zheng X; Tang X; Zang Z; Li B; He S; Shen R; Yang H; Li S
J Endocrinol Invest; 2021 Sep; 44(9):1947-1959. PubMed ID: 33559847
[TBL] [Abstract][Full Text] [Related]
11. Regulating the CCNB1 gene can affect cell proliferation and apoptosis in pituitary adenomas and activate epithelial-to-mesenchymal transition.
Li B; Zhu HB; Song GD; Cheng JH; Li CZ; Zhang YZ; Zhao P
Oncol Lett; 2019 Nov; 18(5):4651-4658. PubMed ID: 31611974
[TBL] [Abstract][Full Text] [Related]
12. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of HMGA1 correlates with tumour invasiveness and proliferation in human pituitary adenomas.
Wang EL; Qian ZR; Rahman MM; Yoshimoto K; Yamada S; Kudo E; Sano T
Histopathology; 2010 Mar; 56(4):501-9. PubMed ID: 20459557
[TBL] [Abstract][Full Text] [Related]
14. [Differential expression of DJ-1 and HSP27 in invasive and non-invasive pituitary adenomas].
Chen W; Shi X; Liu Y; Li C; Xiao Z; Liu Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 May; 37(5):481-4. PubMed ID: 22659660
[TBL] [Abstract][Full Text] [Related]
15. The expression of integrinbeta1 and FAK in pituitary adenomas and their correlation with invasiveness.
Wang F; Shu K; Lei T; Xue D
J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):572-5. PubMed ID: 18846341
[TBL] [Abstract][Full Text] [Related]
16. A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion.
Miao Y; Zong M; Jiang T; Yuan X; Guan S; Wang Y; Zhou D
Pituitary; 2016 Apr; 19(2):194-201. PubMed ID: 26809958
[TBL] [Abstract][Full Text] [Related]
17. Invasiveness of pituitary adenomas.
Sautner D; Saeger W
Pathol Res Pract; 1991 Jun; 187(5):632-6. PubMed ID: 1923959
[TBL] [Abstract][Full Text] [Related]
18. Advancements in the study of miRNA regulation during the cell cycle in human pituitary adenomas.
Zhang T; Yang Z; Gao H
J Neurooncol; 2017 Sep; 134(2):253-258. PubMed ID: 28577032
[TBL] [Abstract][Full Text] [Related]
19. [Expression of pituitary tumor transforming gene, endostatin, and basic fibroblast growth factor mRNAs in invasive pituitary adenomas].
Chen L; Liu YS; Wang LS; Yin HG; Hou QT; Liu ZX; Chen LH; Ling F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):651-3, 666. PubMed ID: 16114549
[TBL] [Abstract][Full Text] [Related]
20. [Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].
He DS; Chen MZ; Wang HJ; Ke CL; Yan C; Zheng H; Hong YS
Ai Zheng; 2002 Oct; 21(10):1124-8. PubMed ID: 12508658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
